Skip to Navigation
Calderdale and Huddersfield NHS Foundation Trust
West Yorkshire and Harrogate, Cancer Alliance
Time period: 2016-20
|
Cancer Alliance |
|
National |
| Number of High Grade Dysplasia patients in audit |
17 |
|
1372 |
|
Cancer Alliance |
|
National |
| Method of Diagnosis |
| – First diagnosis confirmed by second pathologist |
15 |
88.2% |
88.1% |
| Treatment planning |
| – HGD plan discussed at MDT |
17 |
100.0% |
89.7% |
| – Treatment plan for active treatment |
15 |
86.7% |
78.8% |
| First treatment |
| – Endoscopic therapy (such as endoscopic resection) |
15 |
86.7% |
71.8% |
| – Surveillance |
2 |
13.3% |
13.9% |
Time period: 2018-2020
|
Organisation |
|
National |
| Number of oesophago-gastric (OG) cancer patients in audit |
181 |
|
20,319 |
| Case ascertainment for OG cancer (%) |
85-100% |
|
|
| Method of Diagnosis |
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations |
20 |
12.5% |
12.6% |
| – Patients with referral source reported as unknown |
13 |
7.2% |
1.8% |
| Pre-treatment staging of cancer |
| – Patients having staging CT scan recorded |
177 |
97.8% |
85.9% |
| Treatment planning |
| – Patients having a plan for curative treatment |
52 |
28.7% |
39.4% |
| – Patients having a plan for non-curative treatment |
129 |
71.3% |
60.6% |
| – Patients with non-curative plans having chemotherapy or radiotherapy |
32 |
24.8% |
42.8% |
Download this data as a PDF
Copyright © 2022 National Oesophago-Gastric Cancer Audit | Lovingly Crafted by
Mixd